Table 2.
The baseline lipid profiles for EL 2037 T/C and 2237 G/A genotypes in CAD patients
| SNPs | N | TCa (mmol/l) | TG (mmol/l) | HDL-C (mmol/l) | LDL-C (mmol/l) |
|---|---|---|---|---|---|
| 2037 T/C | |||||
| TT | 68 | 4.74 ± 1.00 | 1.98 ± 1.17 | 1.08 ± 0.25 | 2.90 ± 0.87 |
| TC | 47 | 4.47 ± 0.88 | 2.08 ± 1.27 | 1.09 ± 0.36 | 2.64 ± 0.74 |
| CC | 6 | 3.92 ± 0.85 | 1.91 ± 0.57 | 0.82 ± 0.18 | 2.32 ± 0.78 |
| TC + CC | 53 | 4.41 ± 0.89 | 2.06 ± 1.21 | 1.06 ± 0.36 | 2.60 ± 0.74* |
| 2237 G/A | |||||
| GG | 46 | 4.63 ± 1.08 | 1.81 ± 0.95 | 1.04 ± 0.28 | 2.87 ± 0.93 |
| GA | 60 | 4.60 ± 0.85 | 2.21 ± 1.33 | 1.11 ± 0.33 | 2.69 ± 0.75 |
| AA | 15 | 4.45 ± 1.05 | 1.85 ± 1.16 | 1.03 ± 0.24 | 2.81 ± 0.80 |
| GA + AA | 75 | 4.57 ± 0.89 | 2.14 ± 1.30 | 1.09 ± 0.32 | 2.71 ± 0.76 |
SNPs single nucleotide polymorphisms, N number, TC a total cholesterol, TG triglyceride, HDL-C high density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol
* P < 0.05 compared with TT group